Press-release for stocks for bristol-myers squibb company for AZN

| 1.68% | O: 2.24% H: 0.0% C: -0.8%
AZNCF | News | $140.3 -4.19% 1.5K

| 5.31% | O: -3.43% H: 6.21% C: 6.21%
VTRS | News A | $11.55 1.67% 1.65% 7.2M

| -3.73% | O: -0.25% H: 1.1% C: -0.17%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 3.2% | O: -0.05% H: 0.43% C: -0.27%
BMY | $48.86 -0.27% -0.02% 16M

| -4.54% | O: -0.08% H: 0.04% C: -0.35%
BHC | $8.56 0.35% 0.0% 2M

| -18.06% | O: 0.38% H: 0.0% C: -7.27%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 0.96% | O: 0.77% H: 1.63% C: 0.35%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| 0.29% | O: 0.84% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 5.04% | O: 0.18% H: 0.3% C: 0.19%
eczema dermatitis set therapeutics market

Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

| -7.83% | O: 0.99% H: 0.0% C: 0.0%
SNYNF | News | $94.25 -2.18% 480

| -5.47% | O: -1.17% H: 0.0% C: -0.89%
AZNCF | News | $140.3 -4.19% 1.5K

| 4.15% | O: 0.89% H: 0.78% C: 0.78%
NVSEF | News | $96.0 6.88% 52K

| 0.33% | O: -100.0% H: NaN% C: Infinity%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 3.11% | O: 0.52% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| -4.07% | O: 0.02% H: 0.51% C: -0.3%
BMY | $48.86 -0.27% -0.02% 16M

| -8.0% | O: 0.26% H: 2.03% C: 1.57%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| -5.99% | O: 0.36% H: 0.72% C: 0.61%
ABT | News | $106.89 -0.65% -0.22% 5.1M

| -3.99% | O: 1.04% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -5.35% | O: -0.96% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 3.79% | O: -0.12% H: 0.25% C: -0.63%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| -4.46% | O: 0.54% H: 0.0% C: 0.0%
abbvie set canada key market

Neuroblastoma Drugs Market to Reach $1.3 Billion, Globally, by 2032 at 6.2% CAGR: Allied Market Research
Published: 2024-02-26 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K

| 8.63% | O: 3.06% H: 0.0% C: -2.34%
LLY | News | $732.2 -1.81% 0.18% 2.1M

| -3.96% | O: 0.23% H: 1.16% C: 0.08%
BMY | $48.86 -0.27% -0.02% 16M

| -5.17% | O: -0.19% H: 0.23% C: -2.02%
UTHR | $237.06 1.11% 1.09% 610K

| 3.28% | O: -0.48% H: 1.17% C: -1.04%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 7.63% | O: 0.38% H: 0.44% C: -0.23%
reach research market

Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

| -8.95% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | News | $94.25 -2.18% 480

| -1.52% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | News | $140.3 -4.19% 1.5K

| 10.47% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | News | $96.0 6.88% 52K

| -5.82% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $65.26 -4.38% 5.9K

| 28.21% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | News | $9.49 -1.11% 480K

| -14.66% | O: -0.27% H: 0.0% C: -1.17%
TAK | News | $13.23 -1.12% 0.0% 920K

| -9.46% | O: -0.2% H: 0.14% C: -0.48%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -3.61% | O: -0.06% H: 0.46% C: 0.29%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| -1.67% | O: -0.69% H: 1.42% C: 1.22%
LLY | News | $732.2 -1.81% 0.18% 2.1M

| -0.92% | O: 2.37% H: 1.51% C: 0.79%
BMY | $48.86 -0.27% -0.02% 16M

| -3.77% | O: -0.65% H: 1.63% C: 1.48%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| -3.85% | O: -0.88% H: 1.46% C: 1.13%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -0.15% | O: 1.67% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 8.85% | O: -2.81% H: 2.08% C: 1.38%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| -3.5% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

| -4.81% | O: 3.52% H: 0.0% C: -1.18%
AZNCF | News | $140.3 -4.19% 1.5K

| 16.27% | O: 0.06% H: 2.34% C: 2.29%
ALPMY | News | $9.49 -1.11% 480K

| -12.29% | O: 0.37% H: 0.74% C: 0.28%
TAK | News | $13.23 -1.12% 0.0% 920K

| -6.74% | O: 0.14% H: 0.35% C: 0.07%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -1.66% | O: -0.34% H: 0.23% C: -1.13%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

| -4.43% | O: 0.7% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 0.41% | O: 1.22% H: 0.07% C: -0.43%
LLY | News | $732.2 -1.81% 0.18% 2.1M

| 0.24% | O: -0.96% H: 1.75% C: 1.75%
BMY | $48.86 -0.27% -0.02% 16M

| -1.53% | O: -0.18% H: 0.48% C: -1.91%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| -2.04% | O: 0.8% H: 0.0% C: 0.0%
ZLAB | $15.66 3.57% 3.45% 430K

| -16.97% | O: -1.15% H: 1.03% C: -1.5%
VRTX | $400.66 -1.05% -1.06% 810K

| -3.25% | O: -0.28% H: 0.49% C: -0.32%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| 1.86% | O: -0.06% H: 0.0% C: 0.0%
IPHA | $2.47 4.22% 4.05% 690

| -8.14% | O: -3.1% H: 1.2% C: -0.8%
INCY | $51.72 0.14% 0.14% 1.5M

| -10.7% | O: 3.8% H: 1.1% C: -1.17%
BIIB | $201.91 4.52% 4.32% 3.3M

| -21.07% | O: -3.72% H: 0.58% C: -3.82%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 15.37% | O: -0.26% H: 0.73% C: -0.36%
ARGX | $375.0 -0.02% -0.02% 200K

| -4.49% | O: -2.3% H: 1.65% C: 0.83%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| -7.1% | O: 0.06% H: 0.31% C: -1.4%
expansion growth market

Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published: 2024-02-12 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K

| 13.6% | O: -0.57% H: 0.04% C: -1.74%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -2.15% | O: -1.46% H: 1.04% C: 0.97%
LLY | News | $732.2 -1.81% 0.18% 2.1M

| -0.15% | O: 0.09% H: 0.0% C: -0.48%
BMY | $48.86 -0.27% -0.02% 16M

| -1.65% | O: 0.02% H: 0.46% C: -0.14%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| -3.12% | O: -0.83% H: 0.7% C: -0.27%
ABT | News | $106.89 -0.65% -0.22% 5.1M

| -4.15% | O: -0.64% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| 0.99% | O: -0.86% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 13.8% | O: -1.77% H: 0.46% C: 0.41%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| -6.04% | O: -0.4% H: 1.6% C: 1.54%
report health treatment care global market

Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published: 2024-02-06 (Crawled : 00:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K

| -14.57% | O: -1.53% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K

| 4.83% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | News | $96.0 6.88% 52K

| -6.68% | O: 0.41% H: 0.0% C: 0.0%
UCBJY | $65.26 -4.38% 5.9K

| 39.56% | O: 1.71% H: 1.28% C: 0.94%
ALPMY | News | $9.49 -1.11% 480K

| -12.86% | O: 0.28% H: 0.18% C: 0.0%
TAK | News | $13.23 -1.12% 0.0% 920K

| -5.76% | O: 0.07% H: 0.42% C: 0.07%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -4.7% | O: 0.09% H: 0.39% C: -0.36%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

| -3.9% | O: 1.47% H: 0.0% C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M

| 4.83% | O: 0.76% H: 4.31% C: 2.11%
BMY | $48.86 -0.27% -0.02% 16M

| -0.55% | O: -0.14% H: 0.35% C: -1.12%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| -0.87% | O: 1.48% H: 0.0% C: 0.0%
VRTX | $400.66 -1.05% -1.06% 810K

| -2.7% | O: 0.15% H: 2.4% C: 0.56%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| 1.14% | O: 1.33% H: 0.0% C: 0.0%
JAZZ | $108.38 -1.18% -1.19% 400K

| -12.06% | O: -0.02% H: 0.0% C: -1.4%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 5.68% | O: -0.4% H: 0.19% C: -0.33%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| -13.46% | O: -0.18% H: 0.0% C: -6.22%
report cancer blood growth market

Biologics Global Market Forecast Report 2024-2034 - Challenges Posed by Patent Expiration for Biologics
Published: 2023-12-22 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480

| -1.63% | O: 3.66% H: 0.0% C: -0.12%
AZNCF | News | $140.3 -4.19% 1.5K

| 7.51% | O: 3.33% H: 0.0% C: -2.93%
NVO | News | $126.16 -1.93% -0.23% 3.1M

| 24.31% | O: -0.31% H: 0.39% C: -0.44%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

| -2.51% | O: 1.09% H: 0.0% C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M

| 29.2% | O: 0.18% H: 0.5% C: -0.46%
BMY | $48.86 -0.27% -0.02% 16M

| -4.43% | O: -0.78% H: 5.15% C: 2.81%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 11.11% | O: 0.58% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -3.43% | O: 1.03% H: 0.0% C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K

| 7.77% | O: 0.52% H: 0.58% C: 0.05%
GILD | $67.07 0.06% 0.06% 8.3M

| -15.08% | O: 0.34% H: 1.02% C: 0.59%
BIIB | $201.91 4.52% 4.32% 3.3M

| -23.9% | O: 0.57% H: 1.36% C: 1.04%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 6.86% | O: 1.06% H: 0.18% C: -1.06%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| -2.07% | O: 0.24% H: 2.03% C: 1.49%
patent report global market

Locally Advanced Pancreatic Cancer Market Report 2023-2028: Recent Advancements in Immunotherapy Inject New Hope into LAPC Market
Published: 2023-11-21 (Crawled : 23:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K

| 11.67% | O: 0.76% H: 0.0% C: -0.05%
BMY | $48.86 -0.27% -0.02% 16M

| 1.05% | O: 0.56% H: 1.53% C: 1.37%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 10.22% | O: -0.89% H: 0.33% C: -0.16%
report hope cancer pancreatic immunotherapy market

Oncology Drugs Market worth $520 billion by 2033 - Exclusive Report by We Market Research
Published: 2023-11-10 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K

| 10.59% | O: 0.1% H: 0.0% C: -2.14%
ALPMY | News | $9.49 -1.11% 480K

| -19.44% | O: -3.48% H: 3.87% C: 3.61%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| -11.32% | O: 0.24% H: 0.22% C: -0.91%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

| -0.24% | O: -1.24% H: 0.0% C: 0.0%
BMY | $48.86 -0.27% -0.02% 16M

| -2.82% | O: 0.4% H: 0.18% C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 22.82% | O: 0.44% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 10.55% | O: -1.33% H: 0.22% C: -0.11%
report research market

Conquering Challenges in the Solid Tumor Market: Your Guide to FDA-EMA Indications, Regulatory Compliance, and Market Access Excellence | Disease Landscape Insights
Published: 2023-09-21 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K

| 2.9% | O: -1.13% H: 0.0% C: -0.63%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

| -7.46% | O: 0.52% H: 0.57% C: -0.56%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 8.33% | O: -0.5% H: 0.26% C: -0.69%
LLY | News | $732.2 -1.81% 0.18% 2.1M

| 28.81% | O: -1.47% H: 0.0% C: 0.0%
BMY | $48.86 -0.27% -0.02% 16M

| -16.66% | O: -0.37% H: 1.54% C: 0.89%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 10.28% | O: -0.04% H: 0.76% C: -0.16%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -15.07% | O: -1.16% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 4.25% | O: 0.19% H: 0.03% C: -1.57%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| 0.77% | O: 0.22% H: 0.15% C: -0.98%
disease tumor market

Nanotechnology Drug Delivery Market to Reach $209.5 Billion, Globally, by 2032 at 9.1% CAGR: Allied Market Research
Published: 2023-07-19 (Crawled : 09:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K

| 4.35% | O: 0.47% H: 1.47% C: 1.47%
NVSEF | News | $96.0 6.88% 52K

| 10.54% | O: -1.97% H: 0.0% C: 0.0%
TEVA | $13.01 -0.68% 7.5M

| 60.02% | O: 1.23% H: 4.13% C: 4.01%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -4.45% | O: 0.61% H: 0.6% C: -0.84%
BMY | $48.86 -0.27% -0.02% 16M

| -20.98% | O: 0.19% H: 1.19% C: -0.1%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 6.11% | O: 1.5% H: 0.75% C: -0.32%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| 17.62% | O: 0.18% H: 0.67% C: -0.4%
drug reach research market

Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published: 2023-06-30 (Crawled : 23:00) - prnewswire.com
ALKS | $24.66 1.65% 1.62% 1.7M

| Email alert Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M

| Email alert Add to watchlist
NBIX | News M | $138.91 -0.84% -0.85% 880K

| Email alert Add to watchlist
SNYNF | News | $94.25 -2.18% 480

| Email alert Add to watchlist
UCBJY | $65.26 -4.38% 5.9K

| Email alert Add to watchlist
UCBJF | $128.725 -39.66% 750

| Email alert Add to watchlist
AZNCF | News | $140.3 -4.19% 1.5K

| Email alert Add to watchlist
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| Email alert Add to watchlist
TAK | News | $13.23 -1.12% 0.0% 920K

| Email alert Add to watchlist
NVSEF | News | $96.0 6.88% 52K

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M

| Email alert Add to watchlist
BMY | $48.86 -0.27% -0.02% 16M

| Email alert Add to watchlist
AZN | News | $71.175 0.46% 0.46% 6.1M

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380

| Email alert Add to watchlist
LLY | News | $732.2 -1.81% 0.18% 2.1M

| Email alert Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M

| Email alert Add to watchlist
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| Email alert Add to watchlist
report business life global therapeutics

Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published: 2023-06-27 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

| 7.57% | O: -1.1% H: 0.0% C: 0.0%
TAK | News | $13.23 -1.12% 0.0% 920K

| -15.38% | O: -0.95% H: 0.19% C: -0.32%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| -28.65% | O: 0.19% H: 0.11% C: -1.46%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -0.65% | O: -0.01% H: 0.16% C: -0.32%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

| -8.54% | O: 0.03% H: 0.12% C: -0.24%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 13.7% | O: -0.91% H: 0.56% C: -0.5%
LLY | News | $732.2 -1.81% 0.18% 2.1M

| 63.23% | O: 2.15% H: 1.18% C: 0.43%
BMY | $48.86 -0.27% -0.02% 16M

| -24.39% | O: -0.06% H: 0.46% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

| -1.23% | O: -0.21% H: 0.42% C: 0.13%
report business cancer treat global

Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published: 2023-06-08 (Crawled : 02:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K

| -4.49% | O: 0.07% H: 0.0% C: -1.7%
NVSEF | News | $96.0 6.88% 52K

| 17.13% | O: 1.32% H: 0.0% C: -0.62%
TAK | News | $13.23 -1.12% 0.0% 920K

| -17.06% | O: -0.62% H: 0.88% C: 0.81%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 0.37% | O: 1.26% H: 1.08% C: 0.91%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 20.02% | O: 0.41% H: 0.68% C: 0.64%
LLY | News | $732.2 -1.81% 0.18% 2.1M

| 69.36% | O: -0.11% H: 2.66% C: 2.24%
BMY | $48.86 -0.27% -0.02% 16M

| -24.82% | O: 0.28% H: 0.42% C: -0.05%
BNTX | News | $88.18 -0.35% -0.35% 280K

| -19.12% | O: 0.39% H: 0.15% C: -0.79%
AZN | News | $71.175 0.46% 0.46% 6.1M

| -3.36% | O: -0.23% H: 1.83% C: 1.52%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| 23.63% | O: 0.0% H: 0.28% C: -0.23%
metabolic report cancer global therapeutics growth market

Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
Published: 2023-06-01 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480

| -7.07% | O: -0.56% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K

| -5.01% | O: -0.74% H: 1.4% C: 0.35%
NVSEF | News | $96.0 6.88% 52K

| 18.53% | O: 0.99% H: 0.0% C: 0.0%
TAK | News | $13.23 -1.12% 0.0% 920K

| -16.02% | O: 1.32% H: 0.31% C: 0.12%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| -30.77% | O: 0.6% H: 1.07% C: 0.29%
NVO | News | $126.16 -1.93% -0.23% 3.1M

| -18.57% | O: -1.84% H: 1.62% C: 1.33%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 1.8% | O: 1.03% H: 0.84% C: 0.82%
BMY | $48.86 -0.27% -0.02% 16M

| -24.26% | O: 0.37% H: 1.34% C: 1.14%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -6.33% | O: 1.05% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

| -2.73% | O: 0.11% H: 0.69% C: -0.45%
report global therapeutics growth market

Head and Neck Cancer Market Worth US$ 5.0 billion by 2032, with a CAGR of 12.9% during the Forecast Period
Published: 2023-05-24 (Crawled : 10:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K

| -5.16% | O: -1.2% H: 0.0% C: -1.65%
LLY | News | $732.2 -1.81% 0.18% 2.1M

| 74.63% | O: 0.19% H: 1.17% C: 0.42%
BMY | $48.86 -0.27% -0.02% 16M

| -26.36% | O: 0.11% H: 0.14% C: -1.7%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -13.41% | O: 0.14% H: 0.1% C: -0.83%
AZN | News | $71.175 0.46% 0.46% 6.1M

| -4.35% | O: -1.56% H: 0.25% C: -0.71%
cancer market

Global Blood Cancer Drugs Market Report 2023: Increasing Prevalence of Blood Cancer Cases Drives Growth
Published: 2023-05-16 (Crawled : 22:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K

| -7.21% | O: -1.32% H: 0.92% C: -1.34%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

| -6.08% | O: 0.28% H: 0.17% C: -0.5%
BMY | $48.86 -0.27% -0.02% 16M

| -26.9% | O: 0.06% H: 0.43% C: -0.79%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 18.32% | O: -0.19% H: 0.35% C: 0.23%
AZN | News | $71.175 0.46% 0.46% 6.1M

| -5.88% | O: 0.07% H: 0.03% C: -0.84%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| 20.04% | O: -0.82% H: 0.03% C: -0.44%
report cancer blood global growth market

Infrastructure as a Service (IaaS) Market Size is Projected to Reach USD 482 Billion by 2030, Growing at a CAGR of 25.35%: Facts & Factors
Published: 2023-05-10 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K

| -5.9% | O: 0.63% H: 0.64% C: 0.64%
ORCL | News | $115.34 0.22% -0.3% 5.2M

| 19.71% | O: 0.68% H: 0.91% C: 0.75%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

| -7.07% | O: 0.09% H: 0.48% C: 0.28%
LLY | News | $732.2 -1.81% 0.18% 2.1M

| 72.52% | O: -0.54% H: 2.89% C: 2.31%
BMY | $48.86 -0.27% -0.02% 16M

| -27.96% | O: 0.25% H: 1.14% C: 0.47%
BHC | $8.56 0.35% 0.0% 2M

| 45.56% | O: 0.68% H: 1.53% C: 0.85%
BABA | $74.63 2.92% -1.27% 16M

Retail Trade

| -11.81% | O: -0.1% H: 2.87% C: 0.99%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 15.47% | O: -0.21% H: 0.32% C: -0.07%
MSFT | News 4 | $408.94 0.34% 0.33% 14M

| 32.76% | O: 0.53% H: 1.42% C: 1.2%
AZN | News | $71.175 0.46% 0.46% 6.1M

| -5.63% | O: -0.53% H: 0.5% C: 0.25%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| 16.68% | O: 0.2% H: 0.05% C: -0.33%
service reach growing market

Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published: 2023-03-06 (Crawled : 20:00) - prnewswire.com
CMXHF | $176.0 -19.21% 50

n/a

| -10.35% | O: -0.86% H: 0.33% C: 0.33%
CSLLY | $90.71 3.3% 35K

n/a

| -8.42% | O: -0.02% H: 0.54% C: -1.7%
AZNCF | News | $140.3 -4.19% 1.5K

| 7.76% | O: -2.57% H: 1.62% C: 1.62%
TMO | News | $577.39 0.49% 0.0% 2M

| 1.24% | O: 0.41% H: 0.39% C: -2.14%
TEVA | $13.01 -0.68% 7.5M

| 31.28% | O: -1.21% H: 0.43% C: -3.58%
TAK | News | $13.23 -1.12% 0.0% 920K

| -14.67% | O: 0.83% H: 0.06% C: -1.2%
PRGO | $31.23 2.43% 0.0% 960K

| -17.51% | O: 0.76% H: 1.91% C: 1.26%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 19.71% | O: 0.32% H: 0.17% C: -1.53%
LLY | News | $732.2 -1.81% 0.18% 2.1M

| 131.71% | O: 0.01% H: 0.42% C: -2.62%
CTLT | $55.95 -0.14% 0.0% 2M

| -21.46% | O: 0.11% H: 0.53% C: -5.05%
BMY | $48.86 -0.27% -0.02% 16M

| -28.9% | O: 0.41% H: 0.04% C: -1.71%
ALB | News | $115.27 0.93% -0.23% 2.2M

Process Industries

| -55.54% | O: -0.95% H: 1.02% C: -2.19%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 9.18% | O: 0.19% H: 0.06% C: -1.7%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -1.4% | O: 0.65% H: 0.0% C: 0.0%
GILD | $67.07 0.06% 0.06% 8.3M

| -17.36% | O: 0.23% H: 0.0% C: -1.25%
BIIB | $201.91 4.52% 4.32% 3.3M

| -28.52% | O: 0.28% H: 0.0% C: -2.26%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 9.74% | O: 0.9% H: 0.28% C: -1.3%
global report market

← Previous
1
2
3
4
Next →

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M

Consumer Services

BOF | $1.99 70.09% 41.21% 110M

ILAG | $0.51 6.03% 40.62% 1.7M

LICN | $0.941 68.04% 40.49% 15M

AMST | $3.31 65.5% 39.58% 70M

MTC | $3.615 61.38% 38.04% 9.3M

WIMI | $1.15 58.53% 36.92% 19M